Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,895,816 papers from all fields of science
Search
Sign In
Create Free Account
DS Stage I Plasma Cell Myeloma
Known as:
plasma cell neoplasm, stage I
, Stage I Plasma Cell Myeloma
, Multiple Myeloma Stage I
Expand
Plasma cell myeloma with all of the following: 1. Hemoglobin greater than 10 g/Dl, 2. Normal serum calcium, 3. Normal bone structure, 4. Low…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
33 relations
Atypical lymphocyte
B lymphoblast
B-Lymphocytes
Chromosome 8 deletion
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
In vivo potential of recombinant granulysin against human tumors
Sameer Al-Wasaby
,
D. de Miguel
,
+4 authors
A. Anel
Oncoimmunology
2015
Corpus ID: 36790946
9 kDa granulysin is a protein present in the granules of human CTL and NK cells, with cytolytic activity against microbes and…
Expand
2012
2012
Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of multiple myeloma: initial clinical efficiency results
M. Takasu
,
Chihiro Tani
,
+8 authors
K. Awai
European Radiology
2012
Corpus ID: 37813968
ObjectivesTo evaluate the effectiveness of the iterative decomposition of water and fat with echo asymmetric and least-squares…
Expand
Review
2011
Review
2011
Guidelines for supportive care in multiple myeloma 2011
J. Snowden
,
S. Ahmedzai
,
+8 authors
J. Bird
British Journal of Haematology
2011
Corpus ID: 11239214
Supportive care plays an increasingly important role in the modern management of multiple myeloma. While modern treatments have…
Expand
Review
2009
Review
2009
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri
,
R. Kyle
,
+30 authors
B. Durie
Leukemia
2009
Corpus ID: 28720792
The serum immunoglobulin-free light chain (FLC) assay measures levels of free κ and λ immunoglobulin light chains. There are…
Expand
Review
2008
Review
2008
Pathophysiological underpinnings of multiple myeloma progression.
S. Jagannath
Journal of Managed Care Pharmacy
2008
Corpus ID: 24245282
BACKGROUND Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in the bone marrow. Myeloma is…
Expand
Review
2008
Review
2008
CS 1 , a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
E. Hsi
,
R. Steinle
,
+25 authors
A. Williams
2008
Corpus ID: 40666185
Purpose: We generated a humanized antibody, HuLuc63, which specifically targets CS1 (CCND3 subset 1, CRACC, and SLAMF7), a cell…
Expand
Highly Cited
2007
Highly Cited
2007
The benefit of using whole‐body, low‐dose, nonenhanced, multidetector computed tomography for follow‐up and therapy response monitoring in patients with multiple myeloma
M. Horger
,
L. Kanz
,
+4 authors
C. Driessen
Cancer
2007
Corpus ID: 10174095
The objectives of this study were to assess the status and clinical course of patients with multiple myeloma based on the direct…
Expand
Highly Cited
2006
Highly Cited
2006
International uniform response criteria for multiple myeloma
B. Durie
,
J. Harousseau
,
+26 authors
G. Morgan
Leukemia
2006
Corpus ID: 36723528
Correction to: Leukemia (2006) 20, 1467–1473. doi:10.1038/sj.leu.2404284 It has been identified by the authors that there was an…
Expand
2006
2006
LEADING ARTICLE International uniform response criteria for multiple myeloma
B. Durie
,
J. Harousseau
,
+23 authors
Mirt Uams
2006
Corpus ID: 55697230
BGM Durie, J-L Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, M Gertz, M Dimopoulos, J Westin, P Sonneveld, H Ludwig, G…
Expand
Highly Cited
2003
Highly Cited
2003
Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases
S. Coupland
,
M. Hellmich
,
C. Auw-Haedrich
,
W. R. Lee
,
H. Stein
Graefe's Archive for Clinical and Experimental…
2003
Corpus ID: 19340597
BackgroundTo determine the prognostic value of cell-cycle associated markers in ocular adnexal lymphoma (OAL).MethodsTwo hundred…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE